CEBPZ and acute myeloid leukemia: Marked molecular responses in CBF AML patients treated with GO and intensive chemotherapy have also been independently reported, with 38 out of 43 patients (88.4%) achieving >3-log reduction of transcript level by the end of the second consolidation cycle [33].